APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rofecoxib

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Rofecoxib Market Analysis and Forecast 2026-2032

21 December 2025190 pages

Choose your research edition.

Industry ResearchRofecoxib Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Rofecoxib Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Rofecoxib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rofecoxib Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Rofecoxib Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Rofecoxib market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Rofecoxib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Rofecoxib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Rofecoxib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Rofecoxib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Rofecoxib include Wuhan Xinxin Jiali Biotechnology Co. LTD, Merck, Pfizer, Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD, Chengdu Meinkai Chemical Co. LTD and Tremeau, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Rofecoxib, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Rofecoxib, also provides the sales of main regions and countries. Of the upcoming market potential for Rofecoxib, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Rofecoxib sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Rofecoxib market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Rofecoxib sales, projected growth trends, production technology, application and end-user industry.

Rofecoxib Segment by Company

Wuhan Xinxin Jiali Biotechnology Co. LTD

Merck

Pfizer

Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD

Chengdu Meinkai Chemical Co. LTD

Tremeau

Rofecoxib Segment by Type

Oral Suspension.

Tablet-Form

Rofecoxib Segment by Application

Juvenile Rheumatoid Arthritis

Dysmenorrhea

Migraine

Rheumatoid Arthritis

Acute Pain Conditions

Osteoarthritis

Rofecoxib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rofecoxib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rofecoxib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rofecoxib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Rofecoxib in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Rofecoxib manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rofecoxib sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Rofecoxib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral Suspension. Major Manufacturers Table 3. Tablet-Form Major Manufacturers Table 4. Global Rofecoxib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Juvenile Rheumatoid Arthritis Major Manufacturers Table 6. Dysmenorrhea Major Manufacturers Table 7. Migraine Major Manufacturers Table 8. Rheumatoid Arthritis Major Manufacturers Table 9. Acute Pain Conditions Major Manufacturers Table 10. Osteoarthritis Major Manufacturers Table 11. Rofecoxib Industry Trends Table 12. Rofecoxib Industry Drivers Table 13. Rofecoxib Industry Opportunities and Challenges Table 14. Rofecoxib Industry Restraints Table 15. Global Rofecoxib Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Rofecoxib Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Rofecoxib Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Rofecoxib Revenue Market Share by Region (2021-2026) Table 19. Global Rofecoxib Revenue Market Share by Region (2027-2032) Table 20. Global Rofecoxib Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 21. Global Rofecoxib Sales by Region (2021-2026) & (k units) Table 22. Global Rofecoxib Sales by Region (2027-2032) & (k units) Table 23. Global Rofecoxib Sales Market Share by Region (2021-2026) Table 24. Global Rofecoxib Sales Market Share by Region (2027-2032) Table 25. Global Rofecoxib Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Rofecoxib Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Rofecoxib Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Rofecoxib Sales Market Share by Manufacturers (2021-2026) Table 29. Global Rofecoxib Sales Price (US$/unit) of Manufacturers (2021-2026) Table 30. Global Rofecoxib Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Rofecoxib Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Rofecoxib Manufacturers, Product Type & Application Table 33. Global Rofecoxib Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Rofecoxib by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Rofecoxib Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Rofecoxib Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Rofecoxib Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Rofecoxib Revenue Market Share by Type (2021-2026) Table 40. Global Rofecoxib Revenue Market Share by Type (2027-2032) Table 41. Global Rofecoxib Sales by Type 2021 VS 2025 VS 2032 (k units) Table 42. Global Rofecoxib Sales by Type (2021-2026) & (k units) Table 43. Global Rofecoxib Sales by Type (2027-2032) & (k units) Table 44. Global Rofecoxib Sales Market Share by Type (2021-2026) Table 45. Global Rofecoxib Sales Market Share by Type (2027-2032) Table 46. Global Rofecoxib Price by Type (2021-2026) & (US$/unit) Table 47. Global Rofecoxib Price by Type (2027-2032) & (US$/unit) Table 48. Global Rofecoxib Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Rofecoxib Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Rofecoxib Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Rofecoxib Revenue Market Share by Application (2021-2026) Table 52. Global Rofecoxib Revenue Market Share by Application (2027-2032) Table 53. Global Rofecoxib Sales by Application 2021 VS 2025 VS 2032 (k units) Table 54. Global Rofecoxib Sales by Application (2021-2026) & (k units) Table 55. Global Rofecoxib Sales by Application (2027-2032) & (k units) Table 56. Global Rofecoxib Sales Market Share by Application (2021-2026) Table 57. Global Rofecoxib Sales Market Share by Application (2027-2032) Table 58. Global Rofecoxib Price by Application (2021-2026) & (US$/unit) Table 59. Global Rofecoxib Price by Application (2027-2032) & (US$/unit) Table 60. Wuhan Xinxin Jiali Biotechnology Co. LTD Company Information Table 61. Wuhan Xinxin Jiali Biotechnology Co. LTD Business Overview Table 62. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 63. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product Portfolio Table 64. Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Development Table 65. Merck Company Information Table 66. Merck Business Overview Table 67. Merck Rofecoxib Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Merck Rofecoxib Product Portfolio Table 69. Merck Recent Development Table 70. Pfizer Company Information Table 71. Pfizer Business Overview Table 72. Pfizer Rofecoxib Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Pfizer Rofecoxib Product Portfolio Table 74. Pfizer Recent Development Table 75. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Company Information Table 76. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Business Overview Table 77. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product Portfolio Table 79. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Development Table 80. Chengdu Meinkai Chemical Co. LTD Company Information Table 81. Chengdu Meinkai Chemical Co. LTD Business Overview Table 82. Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Chengdu Meinkai Chemical Co. LTD Rofecoxib Product Portfolio Table 84. Chengdu Meinkai Chemical Co. LTD Recent Development Table 85. Tremeau Company Information Table 86. Tremeau Business Overview Table 87. Tremeau Rofecoxib Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Tremeau Rofecoxib Product Portfolio Table 89. Tremeau Recent Development Table 90. North America Rofecoxib Revenue by Type (2021-2026) & (US$ Million) Table 91. North America Rofecoxib Revenue by Type (2027-2032) & (US$ Million) Table 92. North America Rofecoxib Sales by Type (2021-2026) & (k units) Table 93. North America Rofecoxib Sales by Type (2027-2032) & (k units) Table 94. North America Rofecoxib Sales Price by Type (2021-2026) & (US$/unit) Table 95. North America Rofecoxib Sales Price by Type (2027-2032) & (US$/unit) Table 96. North America Rofecoxib Revenue by Application (2021-2026) & (US$ Million) Table 97. North America Rofecoxib Revenue by Application (2027-2032) & (US$ Million) Table 98. North America Rofecoxib Sales by Application (2021-2026) & (k units) Table 99. North America Rofecoxib Sales by Application (2027-2032) & (k units) Table 100. North America Rofecoxib Sales Price by Application (2021-2026) & (US$/unit) Table 101. North America Rofecoxib Sales Price by Application (2027-2032) & (US$/unit) Table 102. North America Rofecoxib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. North America Rofecoxib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 104. North America Rofecoxib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 105. North America Rofecoxib Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 106. North America Rofecoxib Sales by Country (2021-2026) & (k units) Table 107. North America Rofecoxib Sales by Country (2027-2032) & (k units) Table 108. North America Rofecoxib Sales Price by Country (2021-2026) & (US$/unit) Table 109. North America Rofecoxib Sales Price by Country (2027-2032) & (US$/unit) Table 110. United States Rofecoxib Revenue (2021-2032) & (US$ Million) Table 111. Canada Rofecoxib Revenue (2021-2032) & (US$ Million) Table 112. Mexico Rofecoxib Revenue (2021-2032) & (US$ Million) Table 113. Europe Rofecoxib Revenue by Type (2021-2026) & (US$ Million) Table 114. Europe Rofecoxib Revenue by Type (2027-2032) & (US$ Million) Table 115. Europe Rofecoxib Sales by Type (2021-2026) & (k units) Table 116. Europe Rofecoxib Sales by Type (2027-2032) & (k units) Table 117. Europe Rofecoxib Sales Price by Type (2021-2026) & (US$/unit) Table 118. Europe Rofecoxib Sales Price by Type (2027-2032) & (US$/unit) Table 119. Europe Rofecoxib Revenue by Application (2021-2026) & (US$ Million) Table 120. Europe Rofecoxib Revenue by Application (2027-2032) & (US$ Million) Table 121. Europe Rofecoxib Sales by Application (2021-2026) & (k units) Table 122. Europe Rofecoxib Sales by Application (2027-2032) & (k units) Table 123. Europe Rofecoxib Sales Price by Application (2021-2026) & (US$/unit) Table 124. Europe Rofecoxib Sales Price by Application (2027-2032) & (US$/unit) Table 125. Europe Rofecoxib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. Europe Rofecoxib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 127. Europe Rofecoxib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 128. Europe Rofecoxib Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 129. Europe Rofecoxib Sales by Country (2021-2026) & (k units) Table 130. Europe Rofecoxib Sales by Country (2027-2032) & (k units) Table 131. Europe Rofecoxib Sales Price by Country (2021-2026) & (US$/unit) Table 132. Europe Rofecoxib Sales Price by Country (2027-2032) & (US$/unit) Table 133. Germany Rofecoxib Revenue (2021-2032) & (US$ Million) Table 134. France Rofecoxib Revenue (2021-2032) & (US$ Million) Table 135. U.K. Rofecoxib Revenue (2021-2032) & (US$ Million) Table 136. Italy Rofecoxib Revenue (2021-2032) & (US$ Million) Table 137. Russia Rofecoxib Revenue (2021-2032) & (US$ Million) Table 138. Spain Rofecoxib Revenue (2021-2032) & (US$ Million) Table 139. Netherlands Rofecoxib Revenue (2021-2032) & (US$ Million) Table 140. Switzerland Rofecoxib Revenue (2021-2032) & (US$ Million) Table 141. Sweden Rofecoxib Revenue (2021-2032) & (US$ Million) Table 142. Poland Rofecoxib Revenue (2021-2032) & (US$ Million) Table 143. China Rofecoxib Revenue by Type (2021-2026) & (US$ Million) Table 144. China Rofecoxib Revenue by Type (2027-2032) & (US$ Million) Table 145. China Rofecoxib Sales by Type (2021-2026) & (k units) Table 146. China Rofecoxib Sales by Type (2027-2032) & (k units) Table 147. China Rofecoxib Sales Price by Type (2021-2026) & (US$/unit) Table 148. China Rofecoxib Sales Price by Type (2027-2032) & (US$/unit) Table 149. China Rofecoxib Revenue by Application (2021-2026) & (US$ Million) Table 150. China Rofecoxib Revenue by Application (2027-2032) & (US$ Million) Table 151. China Rofecoxib Sales by Application (2021-2026) & (k units) Table 152. China Rofecoxib Sales by Application (2027-2032) & (k units) Table 153. China Rofecoxib Sales Price by Application (2021-2026) & (US$/unit) Table 154. China Rofecoxib Sales Price by Application (2027-2032) & (US$/unit) Table 155. Asia Rofecoxib Revenue by Type (2021-2026) & (US$ Million) Table 156. Asia Rofecoxib Revenue by Type (2027-2032) & (US$ Million) Table 157. Asia Rofecoxib Sales by Type (2021-2026) & (k units) Table 158. Asia Rofecoxib Sales by Type (2027-2032) & (k units) Table 159. Asia Rofecoxib Sales Price by Type (2021-2026) & (US$/unit) Table 160. Asia Rofecoxib Sales Price by Type (2027-2032) & (US$/unit) Table 161. Asia Rofecoxib Revenue by Application (2021-2026) & (US$ Million) Table 162. Asia Rofecoxib Revenue by Application (2027-2032) & (US$ Million) Table 163. Asia Rofecoxib Sales by Application (2021-2026) & (k units) Table 164. Asia Rofecoxib Sales by Application (2027-2032) & (k units) Table 165. Asia Rofecoxib Sales Price by Application (2021-2026) & (US$/unit) Table 166. Asia Rofecoxib Sales Price by Application (2027-2032) & (US$/unit) Table 167. Asia Rofecoxib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 168. Asia Rofecoxib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 169. Asia Rofecoxib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 170. Asia Rofecoxib Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 171. Asia Rofecoxib Sales by Country (2021-2026) & (k units) Table 172. Asia Rofecoxib Sales by Country (2027-2032) & (k units) Table 173. Asia Rofecoxib Sales Price by Country (2021-2026) & (US$/unit) Table 174. Asia Rofecoxib Sales Price by Country (2027-2032) & (US$/unit) Table 175. Japan Rofecoxib Revenue (2021-2032) & (US$ Million) Table 176. South Korea Rofecoxib Revenue (2021-2032) & (US$ Million) Table 177. India Rofecoxib Revenue (2021-2032) & (US$ Million) Table 178. Australia Rofecoxib Revenue (2021-2032) & (US$ Million) Table 179. Taiwan Rofecoxib Revenue (2021-2032) & (US$ Million) Table 180. Southeast Asia Rofecoxib Revenue (2021-2032) & (US$ Million) Table 181. SAMEA Rofecoxib Revenue by Type (2021-2026) & (US$ Million) Table 182. SAMEA Rofecoxib Revenue by Type (2027-2032) & (US$ Million) Table 183. SAMEA Rofecoxib Sales by Type (2021-2026) & (k units) Table 184. SAMEA Rofecoxib Sales by Type (2027-2032) & (k units) Table 185. SAMEA Rofecoxib Sales Price by Type (2021-2026) & (US$/unit) Table 186. SAMEA Rofecoxib Sales Price by Type (2027-2032) & (US$/unit) Table 187. SAMEA Rofecoxib Revenue by Application (2021-2026) & (US$ Million) Table 188. SAMEA Rofecoxib Revenue by Application (2027-2032) & (US$ Million) Table 189. SAMEA Rofecoxib Sales by Application (2021-2026) & (k units) Table 190. SAMEA Rofecoxib Sales by Application (2027-2032) & (k units) Table 191. SAMEA Rofecoxib Sales Price by Application (2021-2026) & (US$/unit) Table 192. SAMEA Rofecoxib Sales Price by Application (2027-2032) & (US$/unit) Table 193. SAMEA Rofecoxib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 194. SAMEA Rofecoxib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 195. SAMEA Rofecoxib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 196. SAMEA Rofecoxib Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 197. SAMEA Rofecoxib Sales by Country (2021-2026) & (k units) Table 198. SAMEA Rofecoxib Sales by Country (2027-2032) & (k units) Table 199. SAMEA Rofecoxib Sales Price by Country (2021-2026) & (US$/unit) Table 200. SAMEA Rofecoxib Sales Price by Country (2027-2032) & (US$/unit) Table 201. Brazil Rofecoxib Revenue (2021-2032) & (US$ Million) Table 202. Argentina Rofecoxib Revenue (2021-2032) & (US$ Million) Table 203. Chile Rofecoxib Revenue (2021-2032) & (US$ Million) Table 204. Colombia Rofecoxib Revenue (2021-2032) & (US$ Million) Table 205. Peru Rofecoxib Revenue (2021-2032) & (US$ Million) Table 206. Saudi Arabia Rofecoxib Revenue (2021-2032) & (US$ Million) Table 207. Israel Rofecoxib Revenue (2021-2032) & (US$ Million) Table 208. UAE Rofecoxib Revenue (2021-2032) & (US$ Million) Table 209. Turkey Rofecoxib Revenue (2021-2032) & (US$ Million) Table 210. Iran Rofecoxib Revenue (2021-2032) & (US$ Million) Table 211. Egypt Rofecoxib Revenue (2021-2032) & (US$ Million) Table 212. Key Raw Materials Table 213. Raw Materials Key Suppliers Table 214. Rofecoxib Distributors List Table 215. Rofecoxib Customers List Table 216. Research Programs/Design for This Report Table 217. Authors List of This Report Table 218. Secondary Sources Table 219. Primary Sources List of Figures Figure 1. Rofecoxib Image Figure 2. Global Rofecoxib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rofecoxib Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral Suspension. Image Figure 5. Tablet-Form Image Figure 6. Global Rofecoxib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Rofecoxib Market Size Share 2021 VS 2025 VS 2032 Figure 8. Juvenile Rheumatoid Arthritis Image Figure 9. Dysmenorrhea Image Figure 10. Migraine Image Figure 11. Rheumatoid Arthritis Image Figure 12. Acute Pain Conditions Image Figure 13. Osteoarthritis Image Figure 14. Global Rofecoxib Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Rofecoxib Revenue (2021-2032) & (US$ Million) Figure 16. Global Rofecoxib Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Rofecoxib Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Rofecoxib Revenue Market Share by Region (2021-2032) Figure 19. Global Rofecoxib Sales (2021-2032) & (k units) Figure 20. Global Rofecoxib Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 21. Global Rofecoxib Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Rofecoxib Sales YoY (2021-2032) & (k units) Figure 23. Europe Rofecoxib Sales YoY (2021-2032) & (k units) Figure 24. China Rofecoxib Sales YoY (2021-2032) & (k units) Figure 25. Asia (Excluding China) Rofecoxib Sales YoY (2021-2032) & (k units) Figure 26. South America, Middle East and Africa Rofecoxib Sales YoY (2021-2032) & (k units) Figure 27. Global Rofecoxib Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Rofecoxib Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Rofecoxib Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Rofecoxib Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Rofecoxib Revenue Market Share by Type (2021-2032) Figure 33. Global Rofecoxib Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 34. Global Rofecoxib Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Rofecoxib Sales Market Share by Type (2021-2032) Figure 36. Global Rofecoxib Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Rofecoxib Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Rofecoxib Revenue Market Share by Application (2021-2032) Figure 39. Global Rofecoxib Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 40. Global Rofecoxib Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Rofecoxib Sales Market Share by Application (2021-2032) Figure 42. North America Rofecoxib Revenue Share by Type (2021-2032) Figure 43. North America Rofecoxib Sales Share by Type (2021-2032) Figure 44. North America Rofecoxib Revenue Share by Application (2021-2032) Figure 45. North America Rofecoxib Sales Share by Application (2021-2032) Figure 46. North America Rofecoxib Revenue Share by Country (2021-2032) Figure 47. North America Rofecoxib Sales Share by Country (2021-2032) Figure 48. Europe Rofecoxib Revenue Share by Type (2021-2032) Figure 49. Europe Rofecoxib Sales Share by Type (2021-2032) Figure 50. Europe Rofecoxib Revenue Share by Application (2021-2032) Figure 51. Europe Rofecoxib Sales Share by Application (2021-2032) Figure 52. Europe Rofecoxib Revenue Share by Country (2021-2032) Figure 53. Europe Rofecoxib Sales Share by Country (2021-2032) Figure 54. China Rofecoxib Revenue Share by Type (2021-2032) Figure 55. China Rofecoxib Sales Share by Type (2021-2032) Figure 56. China Rofecoxib Revenue Share by Application (2021-2032) Figure 57. China Rofecoxib Sales Share by Application (2021-2032) Figure 58. Asia Rofecoxib Revenue Share by Type (2021-2032) Figure 59. Asia Rofecoxib Sales Share by Type (2021-2032) Figure 60. Asia Rofecoxib Revenue Share by Application (2021-2032) Figure 61. Asia Rofecoxib Sales Share by Application (2021-2032) Figure 62. Asia Rofecoxib Revenue Share by Country (2021-2032) Figure 63. Asia Rofecoxib Sales Share by Country (2021-2032) Figure 64. SAMEA Rofecoxib Revenue Share by Type (2021-2032) Figure 65. SAMEA Rofecoxib Sales Share by Type (2021-2032) Figure 66. SAMEA Rofecoxib Revenue Share by Application (2021-2032) Figure 67. SAMEA Rofecoxib Sales Share by Application (2021-2032) Figure 68. SAMEA Rofecoxib Revenue Share by Country (2021-2032) Figure 69. SAMEA Rofecoxib Sales Share by Country (2021-2032) Figure 70. Rofecoxib Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Rofecoxib Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Suspension.
  • Tablet-Form
Applications
  • Juvenile Rheumatoid Arthritis
  • Dysmenorrhea
  • Migraine
  • Rheumatoid Arthritis
  • Acute Pain Conditions
  • Osteoarthritis
Companies covered
  • Wuhan Xinxin Jiali Biotechnology Co. LTD
  • Merck
  • Pfizer
  • Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
  • Chengdu Meinkai Chemical Co. LTD
  • Tremeau

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Rofecoxib Market by Type
  3. 1.2.1 Global Rofecoxib Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral Suspension.
  5. 1.2.3 Tablet-Form
  6. 1.3 Rofecoxib Market by Application
  7. 1.3.1 Global Rofecoxib Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Juvenile Rheumatoid Arthritis
  9. 1.3.3 Dysmenorrhea
  10. 1.3.4 Migraine
  11. 1.3.5 Rheumatoid Arthritis
  12. 1.3.6 Acute Pain Conditions
  13. 1.3.7 Osteoarthritis
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Rofecoxib Market Dynamics
  1. 2.1 Rofecoxib Industry Trends
  2. 2.2 Rofecoxib Industry Drivers
  3. 2.3 Rofecoxib Industry Opportunities and Challenges
  4. 2.4 Rofecoxib Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Rofecoxib Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Rofecoxib Revenue by Region
  3. 3.2.1 Global Rofecoxib Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Rofecoxib Revenue by Region (2021-2026)
  5. 3.2.3 Global Rofecoxib Revenue by Region (2027-2032)
  6. 3.2.4 Global Rofecoxib Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Rofecoxib Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Rofecoxib Sales by Region
  9. 3.4.1 Global Rofecoxib Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Rofecoxib Sales by Region (2021-2026)
  11. 3.4.3 Global Rofecoxib Sales by Region (2027-2032)
  12. 3.4.4 Global Rofecoxib Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Rofecoxib Revenue by Manufacturers
  2. 4.1.1 Global Rofecoxib Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Rofecoxib Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Rofecoxib Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Rofecoxib Sales by Manufacturers
  6. 4.2.1 Global Rofecoxib Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Rofecoxib Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Rofecoxib Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Rofecoxib Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Rofecoxib Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Rofecoxib Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Rofecoxib Manufacturers, Product Type & Application
  13. 4.7 Global Rofecoxib Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Rofecoxib Market CR5 and HHI
  16. 4.8.2 2025 Rofecoxib Tier 1, Tier 2, and Tier 3
5 Rofecoxib Market by Type
  1. 5.1 Global Rofecoxib Revenue by Type
  2. 5.1.1 Global Rofecoxib Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Rofecoxib Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Rofecoxib Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Rofecoxib Sales by Type
  6. 5.2.1 Global Rofecoxib Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Rofecoxib Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Rofecoxib Sales Market Share by Type (2021-2032)
  9. 5.3 Global Rofecoxib Price by Type
6 Rofecoxib Market by Application
  1. 6.1 Global Rofecoxib Revenue by Application
  2. 6.1.1 Global Rofecoxib Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Rofecoxib Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Rofecoxib Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Rofecoxib Sales by Application
  6. 6.2.1 Global Rofecoxib Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Rofecoxib Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Rofecoxib Sales Market Share by Application (2021-2032)
  9. 6.3 Global Rofecoxib Price by Application
7 Company Profiles
  1. 7.1 Wuhan Xinxin Jiali Biotechnology Co. LTD
  2. 7.1.1 Wuhan Xinxin Jiali Biotechnology Co. LTD Company Information
  3. 7.1.2 Wuhan Xinxin Jiali Biotechnology Co. LTD Business Overview
  4. 7.1.3 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product Portfolio
  6. 7.1.5 Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Rofecoxib Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck Rofecoxib Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 Pfizer
  14. 7.3.1 Pfizer Company Information
  15. 7.3.2 Pfizer Business Overview
  16. 7.3.3 Pfizer Rofecoxib Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer Rofecoxib Product Portfolio
  18. 7.3.5 Pfizer Recent Developments
  19. 7.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
  20. 7.4.1 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Company Information
  21. 7.4.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Business Overview
  22. 7.4.3 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product Portfolio
  24. 7.4.5 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Developments
  25. 7.5 Chengdu Meinkai Chemical Co. LTD
  26. 7.5.1 Chengdu Meinkai Chemical Co. LTD Company Information
  27. 7.5.2 Chengdu Meinkai Chemical Co. LTD Business Overview
  28. 7.5.3 Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Chengdu Meinkai Chemical Co. LTD Rofecoxib Product Portfolio
  30. 7.5.5 Chengdu Meinkai Chemical Co. LTD Recent Developments
  31. 7.6 Tremeau
  32. 7.6.1 Tremeau Company Information
  33. 7.6.2 Tremeau Business Overview
  34. 7.6.3 Tremeau Rofecoxib Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Tremeau Rofecoxib Product Portfolio
  36. 7.6.5 Tremeau Recent Developments
8 North America
  1. 8.1 North America Rofecoxib Market Size by Type
  2. 8.1.1 North America Rofecoxib Revenue by Type (2021-2032)
  3. 8.1.2 North America Rofecoxib Sales by Type (2021-2032)
  4. 8.1.3 North America Rofecoxib Price by Type (2021-2032)
  5. 8.2 North America Rofecoxib Market Size by Application
  6. 8.2.1 North America Rofecoxib Revenue by Application (2021-2032)
  7. 8.2.2 North America Rofecoxib Sales by Application (2021-2032)
  8. 8.2.3 North America Rofecoxib Price by Application (2021-2032)
  9. 8.3 North America Rofecoxib Market Size by Country
  10. 8.3.1 North America Rofecoxib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Rofecoxib Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Rofecoxib Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Rofecoxib Market Size by Type
  2. 9.1.1 Europe Rofecoxib Revenue by Type (2021-2032)
  3. 9.1.2 Europe Rofecoxib Sales by Type (2021-2032)
  4. 9.1.3 Europe Rofecoxib Price by Type (2021-2032)
  5. 9.2 Europe Rofecoxib Market Size by Application
  6. 9.2.1 Europe Rofecoxib Revenue by Application (2021-2032)
  7. 9.2.2 Europe Rofecoxib Sales by Application (2021-2032)
  8. 9.2.3 Europe Rofecoxib Price by Application (2021-2032)
  9. 9.3 Europe Rofecoxib Market Size by Country
  10. 9.3.1 Europe Rofecoxib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Rofecoxib Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Rofecoxib Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Rofecoxib Market Size by Type
  2. 10.1.1 China Rofecoxib Revenue by Type (2021-2032)
  3. 10.1.2 China Rofecoxib Sales by Type (2021-2032)
  4. 10.1.3 China Rofecoxib Price by Type (2021-2032)
  5. 10.2 China Rofecoxib Market Size by Application
  6. 10.2.1 China Rofecoxib Revenue by Application (2021-2032)
  7. 10.2.2 China Rofecoxib Sales by Application (2021-2032)
  8. 10.2.3 China Rofecoxib Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Rofecoxib Market Size by Type
  2. 11.1.1 Asia Rofecoxib Revenue by Type (2021-2032)
  3. 11.1.2 Asia Rofecoxib Sales by Type (2021-2032)
  4. 11.1.3 Asia Rofecoxib Price by Type (2021-2032)
  5. 11.2 Asia Rofecoxib Market Size by Application
  6. 11.2.1 Asia Rofecoxib Revenue by Application (2021-2032)
  7. 11.2.2 Asia Rofecoxib Sales by Application (2021-2032)
  8. 11.2.3 Asia Rofecoxib Price by Application (2021-2032)
  9. 11.3 Asia Rofecoxib Market Size by Country
  10. 11.3.1 Asia Rofecoxib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Rofecoxib Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Rofecoxib Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Rofecoxib Market Size by Type
  2. 12.1.1 SAMEA Rofecoxib Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Rofecoxib Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Rofecoxib Price by Type (2021-2032)
  5. 12.2 SAMEA Rofecoxib Market Size by Application
  6. 12.2.1 SAMEA Rofecoxib Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Rofecoxib Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Rofecoxib Price by Application (2021-2032)
  9. 12.3 SAMEA Rofecoxib Market Size by Country
  10. 12.3.1 SAMEA Rofecoxib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Rofecoxib Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Rofecoxib Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Rofecoxib Value Chain Analysis
  2. 13.1.1 Rofecoxib Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Rofecoxib Production Mode & Process
  6. 13.2 Rofecoxib Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Rofecoxib Distributors
  9. 13.2.3 Rofecoxib Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst